Product NDC: | 0069-0201 |
Proprietary Name: | Cladribine |
Non Proprietary Name: | Cladribine |
Active Ingredient(s): | 1 mg/mL & nbsp; Cladribine |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0069-0201 |
Labeler Name: | Pfizer Laboratories Div Pfizer Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200510 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111007 |
Package NDC: | 0069-0201-01 |
Package Description: | 10 mL in 1 VIAL (0069-0201-01) |
NDC Code | 0069-0201-01 |
Proprietary Name | Cladribine |
Package Description | 10 mL in 1 VIAL (0069-0201-01) |
Product NDC | 0069-0201 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cladribine |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20111007 |
Marketing Category Name | ANDA |
Labeler Name | Pfizer Laboratories Div Pfizer Inc. |
Substance Name | CLADRIBINE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Purine Antimetabolite [EPC] |